[Effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis]
- PMID: 28087907
- PMCID: PMC10400839
- DOI: 10.3785/j.issn.1008-9292.2016.09.05
[Effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis]
Abstract
Objective: To investigate the effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis (AR). Methods: Seventy-two Wistar rats were randomly divided into 6 groups:normal control group, AR group, loratadine group, low-dose methyleugenol group, middle-dose methyleugenol group and high-dose methyleugenol group with 12 rats in each group. AR was induced by intraperitoneal injection of ovalbumin in latter 5 groups. 10 mg loratadine q.d was given to rats in loratadine group by gavage; and 10 mg/kg, 20 mg/kg and 40 mg/kg methyleugenol were given by gavege q.d to rats in low-, middle-and high-dose methyleugenol groups, respectively. Nasal mucosa samples were obtained from rats at 1, 2, 4 and 6 weeks after drug intervention. The expression of MUC5AC protein and mRNA in nasal mucosa was detected by immunohistochemistry and real-time fluorescence quota PCR (RT-PCR), respectively. Results: Compared with AR, the percentage of cells staining positively for MUC5AC protein and the relative quantity of MUC5AC mRNA in middle-and high-dose methyleugenol groups were significantly decreased after 2 and 4 weeks of drug intervention (P<0.05), but no such decrease was observed in low-dose methyleugenol group at all time points (P>0.05). The percentage of cells with positive expression of MUC5AC protein and mRNA in loratadine group were significantly decreased after 1 week of administration (P<0.05). The percentage of cells with positive MUC5AC protein in middle-dose methyleugenol group was higher than that in loratadine group (P<0.05) after 6 week of drug intervention, but the difference was not seen in high-dose group (P>0.05). There was no significant difference in relative quantities of MUC5AC mRNA after 4 weeks of administration between high-and middle-dose methyeugenol groups and loratadine group (P>0.05). Conclusion: Methyleugenol can attenuate AR through inhibiting the expression of MUC5AC mRNA and protein in nasal mucosa of AR rats.
目的: 观察甲基丁香酚对变应性鼻炎大鼠鼻黏膜中黏蛋白5AC(MUC5AC)的影响。
方法: 将72只Wistar大鼠分为正常对照组(12只)和造模组(60只),卵清蛋白致敏Wistar大鼠建立变态性鼻炎动物模型。造模成功后,大鼠随机分为模型对照组、氯雷他定组和甲基丁香酚小、中、大剂量组(10 mg/kg、20 mg/kg、40 mg/kg),各组给药干预,分别在干预1周、2周、4周和6周后取材,采用免疫组织化学检测和实时定量PCR检测MUC5AC mRNA及其蛋白的表达。
结果: MUC5AC蛋白阳性表达细胞百分率及MUC5AC mRNA表达量小剂量组在整个干预过程中与模型对照组差异无统计学意义(均 P>0.05);大、中剂量组分别在干预2周和4周后明显减少,差异均有统计学意义(均 P < 0.05);氯雷他定组在干预1周后明显减少,差异有统计学意义( P < 0.05)。与氯雷他定组MUC5AC蛋白阳性表达细胞百分率比较:中剂量组在干预6周后依然较高( P < 0.05),大剂量组在干预6周后差异无统计学意义( P>0.05)。与氯雷他定组MUC5AC mRNA表达量比较,大、中剂量组在干预4周后差异均无统计学意义(均 P>0.05)。
结论: 甲基丁香酚可以显著抑制变应性鼻炎大鼠鼻黏膜中黏蛋白MUC5AC的表达,进而对变应性鼻炎有一定的抑制作用,可为临床应用研究提供依据。
Similar articles
-
[Effect of methyl eugenol on nasal mucosal aquaporin 5 in rats with allergic rhinitis].Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Dec 18;51(6):1036-1041. doi: 10.19723/j.issn.1671-167X.2019.06.010. Beijing Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31848500 Free PMC article. Chinese.
-
[Acupoint injection inhibiting abnormal secretion of mucin and inflammatory reaction of nasal mucosa in rats with allergic rhinitis through the p38 mitogen-activated protein kinase pathway].Zhen Ci Yan Jiu. 2024 Nov 25;49(11):1160-1167. doi: 10.13702/j.1000-0607.20230913. Zhen Ci Yan Jiu. 2024. PMID: 39557432 Chinese.
-
[The inhibition of 18β-sodium glycyrrhetinic acid on thymic stromal lymphopoietin expression in the nasal mucosa of allergic rhinitis rats].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jun 7;54(6):456-463. doi: 10.3760/cma.j.issn.1673-0860.2019.06.011. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31262112 Chinese.
-
[Effects of 18β-glycyrrhetinic Acid on the Expression of CCL11, AQP1 and EOS in Nasal Mucosa of Allergic Rhinitis Rats].Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 May;46(3):389-93. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26121859 Chinese.
-
Mucin 5 subtype AC expression and upregulation in the nasal mucosa of allergic rhinitis rats.Otolaryngol Head Neck Surg. 2012 Dec;147(6):1012-9. doi: 10.1177/0194599812460977. Epub 2012 Sep 12. Otolaryngol Head Neck Surg. 2012. PMID: 22972875
References
-
- 梁 少瑜, 谭 晓梅, 曾 永长, et al. 细辛挥发油对过敏性鼻炎豚鼠鼻黏膜和组胺影响的初步研究. http://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201102045.htm. 中国实验方剂学杂志. 2011;17(2):149–151. [梁少瑜, 谭晓梅, 曾永长, 等.细辛挥发油对过敏性鼻炎豚鼠鼻黏膜和组胺影响的初步研究[J].中国实验方剂学杂志, 2011, 17(2):149-151.]
-
- 王 龙妹, 傅 惠娣, 周 志兰. 细辛、苍耳子对小鼠干扰素诱生的影响. http://www.cnki.com.cn/Article/CJFDTOTAL-LCZZ1999S1009.htm. 中国临床药学杂志. 1999;8(1):23–25. [王龙妹, 傅惠娣, 周志兰.细辛、苍耳子对小鼠干扰素诱生的影响[J].中国临床药学杂志, 1999, 8(1):23-25.]
-
- 章 育正, 余 上才, 赵 慧娟, et al. 苍耳子和细辛的免疫抑制作用. http://www.cnki.com.cn/Article/CJFDTOTAL-SHMY199306004.htm. 上海免疫学杂志. 1993;13(6):334–336. [章育正, 余上才, 赵慧娟, 等.苍耳子和细辛的免疫抑制作用[J].上海免疫学杂志, 1993, 13(6):334-336.]
-
- 刘 玉红, 易 进海, 黄 蛟, et al. RP-HPLC法同时测定细辛中甲基丁香酚、黄樟醚和细辛脂素的含量. http://www.cnki.com.cn/Article/CJFDTOTAL-YWFX201205024.htm. 药物分析杂志. 2012;32(5):822–825. [刘玉红, 易进海, 黄蛟, 等.RP-HPLC法同时测定细辛中甲基丁香酚、黄樟醚和细辛脂素的含量[J].药物分析杂志, 2012, 32(5):822-825.]
-
- SHIN B K, LEE E H, KIM H M. Suppression of L-histidine decarboxylase mRNA expression by methyleugeol. Biochem Biophys Res Commun. 1997;232(1):188–191. doi: 10.1006/bbrc.1997.6260. [SHIN B K, LEE E H, KIM H M.Suppression of L-histidine decarboxylase mRNA expression by methyleugeol[J].Biochem Biophys Res Commun, 1997, 232(1):188-191.] - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials